Prospect Capital Co. (NASDAQ:PSEC – Get Free Report) declared a monthly dividend on Tuesday, November 12th,Wall Street Journal reports. Investors of record on Friday, December 27th will be paid a dividend of 0.045 per share by the financial services provider on Wednesday, January 22nd. This represents a $0.54 dividend on an annualized basis and a yield of 12.62%. The ex-dividend date of this dividend is Friday, December 27th.
Prospect Capital has increased its dividend payment by an average of 13.6% annually over the last three years. Prospect Capital has a dividend payout ratio of 118.0% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments.
Prospect Capital Price Performance
PSEC stock opened at $4.28 on Thursday. The firm has a 50-day moving average of $5.21 and a two-hundred day moving average of $5.33. The firm has a market capitalization of $1.87 billion, a PE ratio of -16.46 and a beta of 1.00. The company has a current ratio of 0.48, a quick ratio of 0.93 and a debt-to-equity ratio of 0.65. Prospect Capital has a one year low of $4.15 and a one year high of $6.30.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on PSEC shares. Wells Fargo & Company reduced their price objective on Prospect Capital from $5.00 to $4.50 and set an “underweight” rating for the company in a research report on Friday, August 30th. StockNews.com cut Prospect Capital from a “hold” rating to a “sell” rating in a research note on Friday, August 30th.
Get Our Latest Analysis on PSEC
About Prospect Capital
Prospect Capital Corporation is a business development company. It specializes in middle market, mature, mezzanine finance, later stage, emerging growth, leveraged buyouts, refinancing, acquisitions, recapitalizations, turnaround, growth capital, development, capital expenditures and subordinated debt tranches of collateralized loan obligations, cash flow term loans, market place lending and bridge transactions.
See Also
- Five stocks we like better than Prospect Capital
- The 3 Best Retail Stocks to Shop for in August
- Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?”
- Financial Services Stocks Investing
- Unusual Trading Volume in Gerdau: A Signal for Buyers?
- How to Calculate Options Profits
- 3 Stocks Gaining Traction in Their Turnaround Stories
Receive News & Ratings for Prospect Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prospect Capital and related companies with MarketBeat.com's FREE daily email newsletter.